Literature DB >> 19751461

The clinical spectrum of labile hypertension: a management dilemma.

Samuel J Mann1.   

Abstract

J Clin Hypertens (Greenwich). 2009;11:491-497. (c)2009 Wiley Periodicals, Inc.Although the management of the labile component of blood pressure elevation is a problem often encountered by clinicians, there is a paucity of information available to guide therapeutic decisions. This review discusses the clinical relevance of blood pressure lability, the limitations of current knowledge, and possible directions for future research and clinical management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751461      PMCID: PMC8673041          DOI: 10.1111/j.1751-7176.2009.00155.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  36 in total

1.  Pressor responses to noxious stimuli in hypertensive patients. Effects of reserpine and chlorothiazide.

Authors:  A P SHAPIRO
Journal:  Circulation       Date:  1962-08       Impact factor: 29.690

Review 2.  Cardiovascular reactivity to psychosocial stressors. A review of the effects of beta-blockade.

Authors:  P J Mills; J E Dimsdale
Journal:  Psychosomatics       Date:  1991       Impact factor: 2.386

Review 3.  The clinical significance of white-coat and masked hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Roberto Gattobigio; Claudia Borgioni; Claudia Castellani; Mariagrazia Sardone; Gianpaolo Reboldi
Journal:  Blood Press Monit       Date:  2007-12       Impact factor: 1.444

4.  Changes of general haemodynamics during stressful mental arithmetic and non-stressing quiet conversation and modification of the latter by beta-adrenergic blockade.

Authors:  M Ulrych
Journal:  Clin Sci       Date:  1969-06       Impact factor: 6.124

5.  Blood pressure variability at normal and high blood pressure.

Authors:  G Mancia
Journal:  Chest       Date:  1983-02       Impact factor: 9.410

6.  Mechanisms concerned with blood pressure variability throughout the day.

Authors:  J Conway; N Boon; J Vann Jones; P Sleight
Journal:  Clin Exp Hypertens A       Date:  1985

7.  Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions.

Authors:  S J Mann
Journal:  Psychosomatics       Date:  1996 Sep-Oct       Impact factor: 2.386

Review 8.  Severe paroxysmal hypertension (pseudopheochromocytoma).

Authors:  Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

9.  Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man.

Authors:  A P Niarchos; T G Pickering; A Morganti; J H Laragh
Journal:  Clin Exp Hypertens A       Date:  1982

10.  Circulatory effects of stress in essential hypertension.

Authors:  L Andrén; L Hansson
Journal:  Acta Med Scand Suppl       Date:  1981
View more
  7 in total

Review 1.  Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.

Authors:  Samuel J Mann
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 2.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

3.  Estimating cardiovascular health gains from eradicating indoor cold in Australia.

Authors:  Ankur Singh; Anja Mizdrak; Lyrian Daniel; Tony Blakely; Emma Baker; Ludmila Fleitas Alfonzo; Rebecca Bentley
Journal:  Environ Health       Date:  2022-05-17       Impact factor: 7.123

Review 4.  Labile hypertension: a new disease or a variability phenomenon?

Authors:  Elias Sanidas; Charalampos Grassos; Dimitrios P Papadopoulos; Maria Velliou; Kostas Tsioufis; Marina Mantzourani; Despoina Perrea; Dimitrios Iliopoulos; John Barbetseas; Vasilios Papademetriou
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

5.  Endothelial function in children with white-coat hypertension.

Authors:  Alexander Jurko; Tomas Jurko; Milan Minarik; Michal Mestanik; Andrea Mestanikova; Vladimir Micieta; Zuzana Visnovcova; Ingrid Tonhajzerova
Journal:  Heart Vessels       Date:  2018-01-29       Impact factor: 2.037

Review 6.  Pseudopheochromocytoma.

Authors:  Divya Mamilla; Melissa K Gonzales; Murray D Esler; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-18       Impact factor: 4.741

7.  Psychosomatic research in hypertension: the lack of impact of decades of research and new directions to consider.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-07-26       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.